Document Classification

Section Type: RESULTS

Text: In group 1 GH-treated patients, growth velocity, and height-sd score during the first and second years, total 2-yr height gain (18. 5 + / - 2. 4 cm in d3/d3 ; 18. 4 + / - 2. 6 in d3/fl ; 19. 5 + / - 2. 3 in fl/fl), Delta 2-yr height increase (9. 1 + / - 2. 4 cm in d3/d3 ; 9. 4 + / - 3. 0 in d3/fl ; 10. 4 + / - 2. 1 in fl/fl), first-year growth prediction and studentized residual values (0. 08 + / - 1. 26 in d3/d3 ; 0. 28 + / - 1. 21 in d3/fl ; 0. 67 + / - 0. 95 in fl/fl) did not differ among the d3/fl-GHR genotypes.